CAPE CANAVERAL, Fla.--(BUSINESS WIRE)--Starfighters Space, Inc. ("Starfighters†or "the Company†), the innovative aerospace company, owner and operator of the world's largest commercial supersonic aircraft fleet, out of NASA's Kennedy Space Center, today announced the completion of its Initial Public Offering ("IPO†), raising $40 million through the sale of 11,142,061 shares of common stock (the "Common Stock†) at a public offering price of $3.59 per share. This final closing resulted in the issuance o ...

A day that featured the biggest initial public offering in four years also saw the Nasdaq Composite close sharply lower.The tech-heavy index slid 1.8%. The S&P 500 dropped 1.1%. The Dow Jones Industrial Average fell 230 points, or 0.5%. The S&P and Dow extended their respective losing streaks to four days.Struggles for the Nasdaq were in stark contrast to Medline, which surged in its debut on the tech-heavy index under the MDLN ticker. It raised $6.26 billion in the initial public offering, which makes it t ...

Turn to Dan Primac. He's the business editor at Axios who brought our attention to the boring IPO boom last week. Dan, um, does it become much more buzzy next year.>> I think so. And I think, as Leslie said, I think you're going to see more of these deals. I mean, it's worth noting Medline was kind of exceptional in private equity terms anyway, right.This was a deal that was done in 2021. It was a return of so-called club deals. I believe it's the largest healthcare leverage buyout ever.Um, so it was a very ...

IPO Edge hosted a fireside chat on Dec. 9 from the floor of the New York Stock Exchange during the Bloomberg Activism Forum 2025 with Steve Parish, Managing Partner, Equity Capital Markets at ICR Capital. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the current and upcoming IPO market outlook for 2026, how the government shutdown affected previously planned IPOs and delayed them, and more. Watch the full interview below, or click HERE: About Steve Parish Steve s ...

Core Insights - Medline shares experienced a significant increase of nearly 25% during their trading debut, with the stock priced around $36 after an IPO that raised $6.26 billion, marking one of the largest IPOs in recent years [1][4][7] Company Overview - Medline sold over 216 million shares at $29 each, at the higher end of its anticipated range of $26 to $30, with plans to use the proceeds to reduce debt [2][4] - The company offers over 335,000 medical and surgical products, including protective equipment and testing kits, and has reported consistent annual sales growth since its inception [2] Financial Performance - For the first nine months of the year ending September, Medline reported a net income of $977 million on revenues of $20.65 billion, an increase from a net income of $911 million on $18.72 billion in revenue during the same period the previous year [3] Market Context - The IPO marks a recovery in the IPO market, although overall activity remains below the record levels seen in 2021; Medline's IPO is the largest since Rivian's $11.93 billion IPO in 2021 [4][7] Strategic Vision - CEO Jim Boyle expressed that the IPO is expected to enhance Medline's brand, positioning the company as the "Costco of healthcare" for its medical equipment customers, leveraging its private label products and strong supply chain [5]

Medline shares began trading under the ticker 'MDLN' Wednesday in the biggest IPO since 2021. ...

Key Takeaways Medical supply company Medline is set to make its trading debut on the Nasdaq today.The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline is set to start trading on the Nasdaq today, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.  The medical supply giant, which will debut under the "MDLN" stoc ...

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year. The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the IPO market in 2026. Shares of Medline will trade under the symbol "MDLN." The IPO pricing gives Medline a market value of at least $37 billion, based on the shares listed in its regul ...

It's been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump's Liberation Day tariffs in the spring, followed by the longest U.S. government shutdown in history this fall. That's on top of an economy already hit hard by inflation and declining consumer confidence. Yet despite this, there have still been several high-profile and successful initial public offerings throughout the year—especially in the AI and fintech s ...

Smith Collection / Gado / Getty Images Medline says it supplies more than 330,000 medical products to hospitals around the world Key Takeaways Shares of medical supply company Medline soared in their trading debut on the Nasdaq Wednesday. The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline shares surged in their trading debut Wednesday, after the medical supply company rai ...